CFAR
- Company typePrivate
- Founded1994
- HeadquartersLa Jolla, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
CFAR firmographics
Firmographics- Name
- CFAR
- Legal name
- San Diego Center for AIDS Research (SD CFAR), University of California San Diego
- Website
- https://cfar.ucsd.edu
- Company type
- Private
- Founded year
- 1994
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
CFAR industry classification
Industry- Product category
- HIV Research Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Global Health Research, Clinical Trials & Product Development Partnerships (PDPs) (HLAJAOAM)
Keywords
Where CFAR is headquartered
LocationHeadquarters
- HQ city
- La Jolla
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
CFAR business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure
Revenue model
- NIH P30 Grant Funding: Primary funding from NIH Center for AIDS Research P30 grant (P30 AI036214) providing approximately $15 million renewal grant. The grant supports core services, developmental grants, and operational costs across multiple NIH institutes including NIAID, NCI, NICHD, NIDCR, NHLBI, NIDA, NIMH, NIA, NIDDK, NIGMS, NIMHD, FIC, and OAR.
- Developmental and Pilot Grants: Internal grant programs including Developmental Grants, PROPEL Grants, Next Generation Grants (up to $10,000 for postdoctoral fellows), International Pilot grants, and Community Research Kick Start Grants distributed to member institution researchers.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
CFAR product offering
Product offeringCore offering
The San Diego Center for AIDS Research (SD CFAR) is an NIH-funded P30 research consortium at UC San Diego that delivers specialized core laboratory, clinical, biostatistical, and sociobehavioral science services supporting HIV research across member institutions. It operates multiple service cores (Translational Virology, Molecular and Cellular Immunology, Biostatistics and Modeling, Clinical Investigation, Health Equity Sociobehavioral Science, Advanced Technology, International, Developmental, Administrative, Value-added) and distributes internal grants (Developmental, PROPEL, Next Generation, Community Research Kick Start, Clinical Kick Start) along with grant writing support and training programs to HIV investigators.
Product overview
The San Diego Center for AIDS Research (SD CFAR) is an NIH-funded P30 program (P30 AI036214) that operates as a multi-institutional research support consortium rather than a single product. The organization provides a coordinated suite of core laboratory services organized around specialized functional areas: Translational Virology, Biostatistics and Modeling, Clinical Investigation, Developmental Support, Health Equity Sociobehavioral Science, Advanced Technology, Molecular and Cellular Immunology (MCI), International, Administrative, and Value-added Cores. These cores collectively support basic, clinical, behavioral and translational HIV research across member institutions including UC San Diego, Scripps Research, and San Diego State University. Beyond laboratory services, CFAR operates grant programs (Developmental, PROPEL, Next Generation, Community Research Kick Start, Clinical Kick Start), professional development services (Organized Writing Leagues, O-K Review, career development), educational resources (seminars, training videos, manuscript tools), and community-focused research programs like the Last Gift Study.
Differentiator
Problem solved
Functional benefit
Products and services
- Translational Virology Core
Quantifiable outcome
- Multi-institutional collaboration model connecting UCSD, SDSU, Scripps Research, VA San Diego, and La Jolla Institute for Immunology
- +1 more outcomes
Companies that use CFAR
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles2 records
CFAR technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
CFAR partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core.
- Scripps ResearchcorePartner in Molecular and Cellular Immunology Core (MCI). Co-directors include Dr. Dennis Burton (Scripps Research) and Dr. David Looney (UC San Diego). MCI Core provides laboratory locations at Scripps Research. Bryan Briney serves as Associate Director.
- VA San Diego Healthcare SystemcoreMCI Core laboratory location providing BSL 2+ facility for processing biohazardous HIV-infected samples in sorting and live cell preparation for -omics studies.
- La Jolla Institute for ImmunologycorePartner in MCI Core leadership with Dr. Jennifer Dan serving as Leadership Trainee. Contributes expertise in immunology research.
- San Diego State University (SDSU)coreJoined SD CFAR as new member institution in June 2020 after eight-month strategic planning process led by Dr. Eileen Pitpitan. Serves as academic home to behavioral, prevention and intervention scientists conducting HIV research addressing disparities in HIV prevention and care continuum.
- AIDS Clinical Trial Group (ACTG)coreCFAR Translational Virology Core serves the ACTG Virology Specialty Laboratory. Dr. Gianella serves as director of the ACTG Virology Specialty Laboratory and serves on clinical trial protocol teams.
- AntiViral Research Center (AVRC)coreUC San Diego center served by CFAR Translational Virology Core. Dr. Smith and Dr. Gianella work at the AVRC along with their campus laboratories.
- HIV Neurobehavioral Research Center (HNRC)coreCFAR Translational Virology Core Co-Directs the NeuroVirology and Biology Core at the HNRC.
Scale indicators3 records
Recent moves8 records
Expansion highlights4 records
CFAR competitors and assessment
Company assessmentDirect peers
- amfAR (Foundation for AIDS Research): amfAR is a leading nonprofit organization funding HIV/AIDS research globally. Like CFAR, it supports HIV cure, prevention, and treatment research, but functions primarily as a grantmaking foundation rather than providing core laboratory services to investigators.
- Aaron Diamond AIDS Research Center: Aaron Diamond AIDS Research Center at Columbia University is a leading HIV research institute focused on HIV prevention, treatment, and cure research. It conducts biomedical HIV research similar to CFAR's basic and translational virology work.
- Gladstone Institutes: Gladstone Institutes at UCSF conducts HIV cure research, particularly through its Virology and Immunology divisions. It operates as a multi-program biomedical research institute with overlapping HIV research focus and academic medical center affiliation similar to CFAR.
- IAVI (International AIDS Vaccine Initiative): IAVI is a global nonprofit research organization developing vaccines and antibodies for HIV and other infectious diseases. It shares CFAR's HIV research mission and operates as a multi-institutional research consortium with global partnerships.
- La Jolla Institute for Immunology: La Jolla Institute for Immunology is a partner of CFAR and conducts immunology research relevant to HIV, infectious diseases, and vaccines. It is geographically co-located and shares faculty/research leadership with CFAR's MCI Core.
- ACTG (AIDS Clinical Trials Group): ACTG is the world's largest HIV clinical trials network. CFAR's Translational Virology Core serves as the ACTG Virology Specialty Laboratory, making ACTG both a partner and structural peer in HIV clinical research infrastructure.
- HVTN (HIV Vaccine Trials Network): HVTN is an international HIV vaccine clinical trials network headquartered at Fred Hutchinson Cancer Center. Like CFAR, it supports HIV prevention research infrastructure, with overlapping investigator pools and NIH co-funding relationships.
- Scripps Research: Scripps Research is a CFAR partner institution with deep immunology and HIV research capabilities. Co-Director Dennis Burton leads antibody research there, and Scripps infrastructure is integrated into CFAR's MCI Core, making it both a collaborator and structural peer.
Broad incumbents
- Fred Hutchinson Cancer Center (HIV research): Fred Hutchinson Cancer Center conducts significant HIV cure and vaccine research alongside broader oncology work. It is a larger, more established research institution with overlapping HIV research capabilities including the defeatHIV program.
Emerging players
- Wistar Institute: Wistar Institute is an independent biomedical research institute with HIV vaccine and immunology programs. It functions as a peer research organization focused on infectious disease and immunology, similar to CFAR's translational virology focus.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
CFAR social profiles
Digital presenceCFAR financial estimates
Financial estimateRevenue estimate
Valuation estimate
CFAR leadership team
Management profileNumber of profiles
Profiles9 records
CFAR subsidiaries and ownership
Company hierarchySubsidiaries9 records
CFAR funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CFAR M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CFAR
What does CFAR do?
The San Diego Center for AIDS Research (SD CFAR) is an NIH-funded P30 research consortium at UC San Diego that delivers specialized core laboratory, clinical, biostatistical, and sociobehavioral science services supporting HIV research across member institutions. It operates multiple service cores (Translational Virology, Molecular and Cellular Immunology, Biostatistics and Modeling, Clinical Investigation, Health Equity Sociobehavioral Science, Advanced Technology, International, Developmental, Administrative, Value-added) and distributes internal grants (Developmental, PROPEL, Next Generation, Community Research Kick Start, Clinical Kick Start) along with grant writing support and training programs to HIV investigators.
Is CFAR a public or private company?
CFAR is a private company. It is classified as state government owned and is currently operating.
When was CFAR founded?
CFAR was founded in 1994. It employs 1 to 10 people.
Where is CFAR based?
CFAR is headquartered in La Jolla, United States, in the North America region.
How does CFAR make money?
Two revenue lines are on record. NIH P30 Grant Funding is the primary driver. The others are developmental and Pilot Grants.
Who are CFAR's main competitors?
Direct peers on record are amfAR (Foundation for AIDS Research), Aaron Diamond AIDS Research Center, Gladstone Institutes, IAVI (International AIDS Vaccine Initiative), La Jolla Institute for Immunology, ACTG (AIDS Clinical Trials Group), HVTN (HIV Vaccine Trials Network) and Scripps Research. Fred Hutchinson Cancer Center (HIV research) is listed as a broad incumbent. Wistar Institute is listed as an emerging player.
Does CFAR have an API?
No public API is recorded for CFAR.
What industry is CFAR in?
CFAR's product category is HIV Research Services. Its primary akta.pro industry code is HLAJAOAM, Global Health Research, Clinical Trials & Product Development Partnerships (PDPs). Its NAICS code is 541714 and its SIC code is 8731.